Stock MOR2 MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

News MorphoSys AG Deutsche Boerse AG

Equities

MOR2

US6177602025

Market Closed - Deutsche Boerse AG
Other stock markets
 02:04:04 2024-07-12 am EDT 		5-day change 1st Jan Change
16.9 EUR +3.05% Intraday chart for MorphoSys AG +3.05% +101.19%
Jul. 12 Novartis Seeks Squeeze Out Approval at MorphoSys AGM MT
Jun. 26 European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
BU
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
EQ
Novartis Seeks Squeeze Out Approval at MorphoSys AGM
MT
Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQ
AFR: MorphoSys AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
MorphoSys AG: Correction of a release from 18/04/2024 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax
DP
MorphoSys AG(XTRA:MOR) dropped from Germany MDAX Index (Performance)
CI
MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX (Total Return) Index
CI
MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX Index (Price Return)
CI
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
InnoCare Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients
AQ
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15
DP
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
BU
Novartis: towards the filing of a buyout offer for MorphoSys
CF
MorphoSys Set to Delist Following Acquisition by Novartis
MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis
MT
Biotech company Morphosys will soon disappear from the stock exchange
RE
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. MOR2 Stock
  5. News MorphoSys AG